Jackson Square Partners LLC Reduces Position in Walgreens Boots Alliance, Inc. (WBA)

Jackson Square Partners LLC decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 55.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,087,112 shares of the pharmacy operator’s stock after selling 5,152,524 shares during the period. Walgreens Boots Alliance comprises about 1.5% of Jackson Square Partners LLC’s portfolio, making the stock its 25th largest position. Jackson Square Partners LLC owned 0.38% of Walgreens Boots Alliance worth $329,502,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in WBA. Hudock Capital Group LLC raised its stake in Walgreens Boots Alliance by 0.4% in the third quarter. Hudock Capital Group LLC now owns 1,641 shares of the pharmacy operator’s stock valued at $132,000 after buying an additional 7 shares during the last quarter. Signaturefd LLC raised its stake in Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock valued at $150,000 after buying an additional 48 shares during the last quarter. Exane Derivatives raised its stake in Walgreens Boots Alliance by 56.3% in the third quarter. Exane Derivatives now owns 1,884 shares of the pharmacy operator’s stock valued at $152,000 after buying an additional 679 shares during the last quarter. Van Hulzen Asset Management LLC acquired a new stake in Walgreens Boots Alliance during the second quarter valued at approximately $159,000. Finally, Country Trust Bank raised its stake in Walgreens Boots Alliance by 14.5% in the third quarter. Country Trust Bank now owns 2,370 shares of the pharmacy operator’s stock valued at $191,000 after buying an additional 300 shares during the last quarter. 60.15% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 83.31 on Friday. Walgreens Boots Alliance, Inc. has a 52-week low of $75.74 and a 52-week high of $88.00. The company has a market capitalization of $89.93 billion, a price-to-earnings ratio of 22.05 and a beta of 1.20. The firm has a 50 day moving average of $82.55 and a 200-day moving average of $82.16.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.01. The company earned $28.50 billion during the quarter. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The firm’s revenue for the quarter was down 1.8% on a year-over-year basis. During the same quarter last year, the business earned $1.03 earnings per share. Equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 10th. Investors of record on Wednesday, February 15th will be paid a $0.375 dividend. This represents a $1.50 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend is Monday, February 13th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.68%.

COPYRIGHT VIOLATION WARNING: “Jackson Square Partners LLC Reduces Position in Walgreens Boots Alliance, Inc. (WBA)” was first reported by sleekmoney and is owned by of sleekmoney. If you are reading this news story on another site, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be accessed at http://sleekmoney.com/jackson-square-partners-llc-reduces-position-in-walgreens-boots-alliance-inc-wba/1656553.html.

Several research analysts have issued reports on the stock. Leerink Swann set a $90.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, January 8th. Jefferies Group LLC set a $95.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, October 23rd. Atlantic Securities raised shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 target price for the company in a report on Monday, February 6th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $88.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, November 10th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a report on Friday, October 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $91.38.

In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 5,700 shares of the firm’s stock in a transaction that occurred on Monday, November 28th. The shares were sold at an average price of $85.05, for a total transaction of $484,785.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Ornella Barra purchased 124,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, February 7th. The shares were acquired at an average cost of $80.93 per share, with a total value of $10,035,320.00. Following the completion of the transaction, the chief operating officer now directly owns 1,690,336 shares in the company, valued at approximately $136,798,892.48. The disclosure for this purchase can be found here. 13.50% of the stock is owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/jackson-square-partners-llc-reduces-position-in-walgreens-boots-alliance-inc-wba/1656553.html

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *